1 Background: Primary intraosseous squamous cell carcinoma (PIOSCC) is a rare 2 malignant odontogenic tumor that originates from odontogenic epithelial remnants. It is 3 often difficult to definitively diagnose PIOSCC, and hence, extraction or surgical 4 treatment is performed prior to initial diagnosis in most cases. In the present study, we 5 aimed to examine new insights into and prognostic factors of PIOSCC patients admitted 6 to our department. 7 Methods: We extensively reviewed the records of patients who underwent radical 8
Introduction 1
The World Health Organization (WHO) in 2005 described that ameloblastic 2 carcinomas and primary intraosseous squamous cell carcinoma (PIOSCC) are 3 odontogenic carcinomas that originate from odontogenic epithelial remnants 1 . Although 4 the pathogenesis of PIOSCC remains unclear, chronic inflammation from an 5 odontogenic infection has been hypothesized as a key factor in carcinogenesis. 2 A 6 comparison of PIOSCC and mucosal OSCC suggested that the carcinogenic process 7 may be markedly similar, but that both tumors exhibit different sets of oncogenes and 8 tumor markers, which would indicate different genetic pathways. 3
9
In 2005, the WHO indicated 3 subcategories of PIOSCC: a solid tumor that invades 10 the marrow spaces and induces osseous resorption, squamous cancer that arises from the 11 lining of an odontogenic cyst, and a squamous cell carcinoma in association with other 12 benign epithelial odontogenic tumors. 1 Waldron and Mustoe proposed a different 13 classification that has been widely accepted; however, certain more recently described 14 types of odontogenic epithelial malignancies are not included. 4 It is often difficult to 15 definitively diagnose PIOSCC as the lesions need to be distinguished from alveolar 16 carcinoma that could invade the bone from the overlying soft tissues or from tumors that 17 have metastasized to the jaw from a distant site and from primary tumors of maxillary 18 sinus origin. 5
19
The overall prognosis for patients with PIOSCC is reportedly poor. The primarily 20 causes for this poor prognosis include the vague symptoms and aggressive behavior of 21 tumor cells, which lead to tumor growth, frequent local recurrence and lymph node 22 metastasis. 6-9 However, the WHO 2005 report 1,10 and National Comprehensive Cancer In the present study, we reviewed cases of PIOSCC that underwent radical surgery, and 2 elucidated certain novel insights and prognostic factors. We retrospectively reviewed the records of patients who underwent radical surgery 7 for PIOSCC between January 2001 and December 2014, and those who were followed 8 for >1 year. This study was approved by the independent ethics committee of our 9 hospital. Tumor stage was classified according to the TNM classification of the 10 International Union Against Cancer, 10 whereas histologic tumor differentiation was 11 defined according to the WHO classification. The clinicopathological characteristics of the patients are summarized in Table 1 . Positive nodes were detected in 4 patients, although distant metastasis was not observed 10 in any of the patients on imaging. A panoramic examination indicated the presence of a 11 radiolucent lesion in all the cases, and the lesion borders were found to be well-defined 12 in 2 cases ( Fig 1A and B ), irregular in 3 cases (Fig 2A and B) , and non-evaluable in 1 13 case. The greatest dimension of the lesions ranged from 25 to 56mm. Biopsy was 14 performed in 5 patients, and the duration between biopsy and surgery ranged from 8 to 15 36 days. Pathological lymph node metastasis was detected in 3 patients, and positive 24 extracapsular spread (ECS) was observed in 1 patient. Recurrence or distant metastasis was noted in 3 patients, and salvage surgery was required in 2 patients. After the surgery, 1 since 2 patients had unresectable recurrent tumors, systemic chemotherapy (400 mg/m 2 2 for the first injection and 250mg/m 2 Cetuximab, 60-80mg/m 2 Paclitaxel) was performed.
3
Since 1 patient had unresectable recurrent tumors and multiple distant metastases, 4 palliative treatment was performed. Three patients died because of local failure, 5 regional failure, or distant metastasis. At present, the remaining 3 patients are being 6 closely followed (duration of follow-up, 12-74 months). Three patients did not exhibit 7 any evidence of the disease at the final follow-up. The 2-year RFS and OS rates were found to be 50.0% and 41.6% in all cases, 11 respectively (Fig 3) . Moreover, the patients were classified into 2 different groups: 12 (Group A) intervention group, wherein surgery or extraction was performed prior to the 13 initial diagnosis; and (Group B) non-intervention group, wherein no surgery or 14 extraction was performed prior to the initial diagnosis. The RFS and OS rates were 15 examined between the groups. The 1-year RFS rates in the intervention and 16 non-intervention groups were 0% and 100%, respectively (P = 0.0246; Fig 4A) , and a 17 significant correlation in this value was observed between the groups. Moreover, the 18 1-year OS rates in the intervention and non-intervention groups were found to be 66.7% 19 and 100%, respectively (P = 0.052; Fig 4B) . The surface of the tumor was covered by non-ulcerative mucosa without moderate to 23 severe dysplasia or carcinoma in all cases ( Fig 5A) . With regard to the differentiation 24 of PIOSCC according to the WHO classification, 3 cases exhibited a well-differentiated tumor, 2 cases exhibited a moderately differentiated tumor, and 1 1 case exhibited a poorly differentiated tumor. In cases where the PIOSCC arose from 2 cystic lesions, the lesions exhibited hypokeratinizing tumor cells that formed relatively 3 round or ovoid tumor nests with a palisading arrangement of basal cells ( Fig 5B) .
4
Although the sequences between the cyst epithelium and tumor epithelium were not 5 clear, this tumor was confirmed as a PIOSCC originating from odontogenic cysts 6 because cytokeratin 19 immunohistochemical staining yielded positive results in the 7 tumor cells but not in the oral mucosa ( Fig 5C) . In cases where the PIOSCC arose de 8 novo, the growth of tumor cells was observed in the bone marrow of the mandible (Fig   9   5D ). This tumor was not associated with any cystic component and appeared to arise 10 de novo. treatments. In the present study, we aimed to elucidate new insights and the prognostic 17 factors of PIOSCC.
18
PIOSCC is a rare malignant odontogenic tumor that accounts of <2% of all cases of 19 oral SCC. 12, 13 The most common site of PIOSCC ranges from the retromolar region to 20 the ramus of the mandible; the ratio of occurrence at the mandible and maxilla has been 21 found to be 4:1. 7, 14 In the present study, we detected 6 cases of PIOSCC in a series of 22 414 cases of oral SCC; the ratio of occurrence at the mandible and maxilla was similar 23 in these cases.
24
The radiologic findings of PIOSCC are varied, including radiolucent appearance, well-defined lesions with cortical preservation, small or massive amounts of bone 1 resorption, and more aggressive forms with irregular borders. 15 Kaffe et al reported that 2 the radiologic borders of PIOSCC were defined, but non-corticated, in 57% of cases and 3 diffuse in 43% of cases; hence, this feature could be used as a criterion for diagnosis. 14
4
To our knowledge, no cases of root resorption or tooth displacement have been reported 5 thus far. In the present study, we noted 3 cases with diffuse and irregular borders and 2 6 cases with defined borders that were non-corticated.
7
With regard to the histopathologic features of PIOSCC, tumors that arise from the 8 cystic component reportedly show well-differentiated keratinizing carcinomas. In 9 contrast, tumors with de novo origin show less-differentiated keratinizing or 10 non-keratinizing carcinomas. 16 In the present study, however, the histopathologic 11 features were not associated with the site of origin.
12
Most studies, including case reports, have indicated that the prognosis of PIOSCC is 13 poor. [6] [7] [8] [9] 16 One of the reasons underlying this poor prognosis is that the PIOSCC 14 symptoms are vague, and usually involve pain, swelling, and sensory paralysis in the 15 lower lip; moreover, except for cases that are detected incidentally during radiography, 16 the tumor cells in these cases have already invaded the extra jawbone prior to the initial 17 diagnosis. 6, 7, 14 In the present study, none of the cases exhibited tumor cells that were 18 strictly confined to the jawbone. 19 Furthermore, the rate of metastasis in cases of PIOSCC is reported to be 18.1-20 51%, 6, 7, 9, 17 with marked differences between tumors of de novo (36.5%) and cystic 21 origin (4.4%). 9 In the present study, 3 cases were diagnosed as pN (+) and were found to 22 have tumors of de novo origin. In addition, in PIOSCC cases, the local recurrence rate is 23 reportedly 50-60%, 6,18 whereas the 5-year survival rate is reportedly 30-40%, 7,8 with a 24 2-year survival rate of 40-68%. 6, 7, 18 In the present study, local recurrence was only observed in 1 case and the RFS and OS rates were similar among the cases.
1
The NCCN Clinical Practice Guidelines have not described any standard therapy for 2 PIOSCC. However, since the survival rate is consistent with that of other stage IV oral 3 cavity lesions, 7, 8 we believe that the treatment should be similar to that for oral cavity 4 cancers with clinical stage T3N0 or greater. Thus, in the present study, surgery and 5 postoperative RT, with or without concurrent chemotherapy, was performed for 6 high-risk cases, including those with extracapsular spread of lymph node metastasis and 7 positive margins. Elective neck dissection is generally recommended even in patients 8 not diagnosed with cervical lymph node involvement because the reconstruction of hard 9 tissues is required in most of these cases.
10
PIOSCC is often misdiagnosed as periodontitis or pericoronitis based on the imaging 11 findings, and hence, tooth extraction or surgical treatment is commonly performed prior 12 to the initial diagnosis. In these cases, the extracted socket exhibited non-healing, 13 followed by pain, swelling, and sensory paralysis. 9, 19, 20 However, no assessment of the 14 error rate of the preoperative diagnosis of PIOSCC has been performed. To our 15 knowledge, preoperative dental operations were performed in 30 of 53 cases 16 (56.6%). 6, 8, 9, 14, 18, [20] [21] [22] [23] In contrast, the error rate for SCC of the gingiva have been 17 reported to be 25.5% (26 of 102 cases). 24 Although preoperative dental operations are 18 considered to be significantly associated with a poor prognosis in patients with OSCC, 24 19 no investigations of the prognosis of PIOSCC have been performed thus far. A review of 20 previous reports classified 12 of 53 cases who were followed up for > 12 months and 21 could be evaluated into an intervention group and non-intervention group; none of the 6 22 cases in the non-intervention group exhibited any evidence of disease, whereas 3 of the 23 remaining cases in the intervention group exhibited a poor prognosis. 8, 9, 14, 18, [20] [21] [22] In the 24 present study, marked differences in the RFS and OS rates were observed between the intervention group and non-intervention group. The patients who did not undergo 1 treatment prior to the PIOSCC diagnosis exhibited no recurrence. These results 2 suggested that preoperative dental operations in PIOSCC may be a potential prognostic 3 factor. In the intervention group, 2 cases presented with cystic type on radiographs and 4 the other case had been followed for only 12 months. Hence, there may be some biases 5 against the clinical outcome. However, as tumor cells in all the cases had ruptured 6 through the jaw and into the peripheral soft tissues on both radiography and 7 histopathology, there were minimal differences based on the extent of the disease.
8
Thus, we discussed novel insights about PIOSCC and the prognostic factors.
9
Nevertheless, the study has 2 major limitations, including its retrospective nature and 10 the small number of cases. Moreover, there were some biases that were inherent in these 11 studies, including the data recorded by the authors. The management of our department 12 in PIOSCC has been uniformed to reduce biases associated with retrospective study 13 design. In addition, the incidence of PIOSCC is very low among all the cases of OSCC.
14 Hence, an intergroup study with a further number of cases is needed.
15
In conclusion, based on the clinical features of PIOSCC, we believe that the treatment 16 of this condition should be similar to that of oral cancers with clinical stage T3N0 or 
